Menu Close

Articles on Alzheimer's treatment

Displaying all articles

Do the benefits of approving a drug before confirming it works outweigh the potential costs? monkeybusinessimages/iStock via Getty Images Plus

The FDA’s big gamble on the new Alzheimer’s drug

The FDA approved Alzheimer's disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don't yet have.
Currently, the only approved drugs for Alzheimer’s merely alleviate some of the symptoms — partially and temporarily — but do not stop the disease from progressing. (Shutterstock)

Why don’t we have a cure for Alzheimer’s disease?

It was first officially described 115 years ago, but we still do not have a cure for Alzheimer's disease. The human brain is extremely complex, and Alzheimer’s is its most complex disease.

Top contributors

More